Moffitt Cancer Center
Non-profit
Effective treatment starts with the right diagnosis. As with all types of cancer, an early diagnosis can increase the likelihood of a positive outcome. Our multi-specialty medical professionals are dedicated to the treatment and research of cancer, and cancer only.
As Florida’s only National Cancer Institute-designated Comprehensive Cancer Center and one of only 30 leading cancer centers in the U.S. participating in the National Comprehensive Cancer Network, Moffitt is at the very forefront of cancer centers worldwide.
Equipped with top research and care experts working side-by-side, Moffitt is uniquely positioned to revolutionize cancer treatment, elevate care and save more lives.
We're proud to have earned the highest accolades in numerous fields, as shown through our various awards and recognitions. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesMoffitt Cancer Center Leads in IT Innovation and Workplace Excellence
TAMPA, Fla. —Moffitt Cancer Centerhas once againbeen named one ofFoundry’sComputerworld’s Best Places to Work in IT, ranking No. 21 among large organizations on the 2026 list. The annual award honors employers that create exceptional environments for technology professionals and demonstrate a strong commitment to advancing IT talent.
Moffitt Study Reveals Way to Spark Immune Hotspots That Attack Tumors
Key Highlights New biomaterial platform: The system uses a biodegradable chitosan-based hydrogel combined with lipid-coated microparticles that release immune-stimulating chemokines over time. Immune structure formation: When injected in mice, the formulation triggered local accumulation of immune cells that organized into TLS-like structures similar to those found in tumors.
Moffitt Study Shows Immune Structures in Melanoma Could Help Predict Patient Survival
TAMPA, Fla. — A new study has found that certain immune structures may be linked to better survival in patients with melanoma, the deadliest form of skin cancer. The study, led by researchers at Moffitt Cancer Center in collaboration with investigators at UPMC Hillman Cancer Center, was published in the Journal for ImmunoTherapy of Cancer.
Moffitt Study Reveals Promising Combination Therapy for Bladder Cancer
TAMPA, Fla. — Researchers at Moffitt Cancer Center have discovered a new treatment combination that shows promise for patients with muscle-invasive bladder cancer who cannot receive standard-of-care cisplatin-based chemotherapy. The study, published in Nature Medicine, demonstrates that this innovative approach is both safe and efficacious.
Moffitt Cancer Center to Offer Mobile Lung Cancer Screenings to Pasco County Residents
WHO: Moffitt Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, is partnering with the Florida Department of Health in Pasco County to offer low-dose CT scans inside Moffitt’s new mobile lung screening unit. WHAT: For the first time, Pasco County residents will be able to get screened for lung cancer inside Moffitt Cancer Center’s new mobile lung screening unit. Lung cancer is the leading cause of cancer deaths worldwide.
Moffitt Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer
TAMPA, Fla. — A new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through which aging may promote lung cancer progression. Moffitt Cancer Center researchers have found new insights into how metabolic changes associated with aging can impact immune responses against tumors.
Moffitt Cancer Center Earns Family Friendly Business Award
TAMPA, Fla.—Moffitt Cancer Center has been recognized for its workplace policies by Family Friendly Tampa Bay, a local initiative developed to recognize companies that have adopted policies that give Tampa Bay businesses and organizations an advantage in recruiting and retaining the best employees. Moffitt earned a platinum-level designation as a family friendly workplace, the highest recognition available.
Moffitt Cancer Center Bioengineer Receives Prestigious Tribology Gold Medal
TAMPA, Fla. — Greg Sawyer, Ph.D., chair of the Bioengineering Department at Moffitt Cancer Center, has been awarded the 2023 Tribology Gold Medal by the International Tribology Council. This prestigious award is the highest honor in the field and recognizes individuals who have made extraordinary lifetime contributions to the study of friction, wear and lubrication.
Moffitt Cancer Center Earns American Medical Association Joy in Medicine Honor
TAMPA, Fla. — Moffitt Cancer Center has been honored with the American Medical Association’s (AMA) Joy in Medicine distinction. This prestigious recognition is awarded to health care organizations that demonstrate exemplary commitment to physician well-being and meet the rigorous standards of the Joy in Medicine Health System Recognition Program.
CancerX Launches Expanded Accelerator Program for 2025, Partnering With KidsX to Transform Cancer Care Innovation
TAMPA, Fla. — CancerX announced today the launch of its 2025 Accelerator cohort, which will focus on transforming digital innovation and AI solutions in cancer care. This year, CancerX is partnering with KidsX, a nationally recognized community of pediatric hospitals, to create unique opportunities for startups in pediatric oncology.